ir.ziopharm.comInvestors Home | ZIOPHARM Oncology, Inc.
ir.ziopharm.com Profile
ir.ziopharm.com
Maindomain:ziopharm.com
Title:Investors Home | ZIOPHARM Oncology, Inc.
Description：The Investor Relations website contains information about ZIOPHARM Oncology, Inc.'s business for stockholders, potential investors, and financial analysts.
Keywords：Oncology, ziopharm, cancer, research, DNA Thearapeutics, medical, medicine...
Discover ir.ziopharm.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.ziopharm.com Information
| Website / Domain: | ir.ziopharm.com |
| HomePage size: | 58.02 KB |
| Page Load Time: | 0.614786 Seconds |
| Website IP Address: | 173.223.52.137 |
| Isp Server: | Akamai Technologies Inc. |
ir.ziopharm.com Ip Information
| Ip Country: | United States |
| City Name: | Cambridge |
| Latitude: | 42.363597869873 |
| Longitude: | -71.085205078125 |
ir.ziopharm.com Keywords accounting
| Keyword | Count |
|---|---|
| Oncology | 8 |
| ziopharm | 8 |
| cancer | 2 |
| research | 0 |
| DNA Thearapeutics | 0 |
| medical | 3 |
| medicine | 1 |
ir.ziopharm.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1583600061" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Sat, 07 Mar 2020 16:54:21 GMT |
| Link: http://ir.ziopharm.com/; rel="shortlink", http://ir.ziopharm.com/; rel="canonical", https://ir.ziopharm.com/investor-relations; rel="alternate"; hreflang="en", https://ir.ziopharm.com/investor-relations; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| Server: nginx |
| X-Age: 0 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Generator: Drupal 8 (https://www.drupal.org) |
| X-Request-ID: v-4ab3fe9a-6094-11ea-819a-9f3a78cc1b8f |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 12146 |
| X-EdgeConnect-MidMile-RTT: 42, 42 |
| X-EdgeConnect-Origin-MEX-Latency: 508, 508 |
| Cache-Control: public, max-age=0, s-maxage=1800 |
| Expires: Sat, 07 Mar 2020 16:54:21 GMT |
| Date: Sat, 07 Mar 2020 16:54:21 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: SimpleSAMLSessionID=f09d28802f3b4966c87cc5d88a42b280; path=/; secure; HttpOnly, DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
| Strict-Transport-Security: max-age=15768000 ; preload |
ir.ziopharm.com Meta Info
| charset="utf-8"/ |
| content="Investors Home | ZIOPHARM Oncology, Inc." name="title"/ |
| content="ZIOPHARM Oncology, Inc." property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about ZIOPHARM Oncology, Inc.'s business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="https://ir.ziopharm.com/investor-relations" property="og:url"/ |
| content="Investors Home | ZIOPHARM Oncology, Inc." property="og:title"/ |
| content="Oncology, ziopharm, cancer, research, DNA Thearapeutics, medical, medicine" name="keywords"/ |
| content="no-referrer" name="referrer"/ |
| content="The Investor Relations website contains information about ZIOPHARM Oncology, Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
173.223.52.137 Domains
| Domain | WebSite Title |
|---|
ir.ziopharm.com Similar Website
| Domain | WebSite Title |
|---|---|
| Investors Home | ZIOPHARM Oncology, Inc. | |
| Oncology | Oncology | Stanford Medicine | |
| Radiation Oncology: Radiotherapy, SBRT, Brachytherapy | UCLA Radiation Oncology, Los Angeles, CA. | |
| Annual Oncology Nursing Conference | San Antonio, TX | Oncology Nursing Society | |
| Charleston Oncology: Medical Oncology and Hematology Specialists: Charleston, SC | |
| American Society for Radiation Oncology (ASTRO), ASTRO Radiation Oncology Career Center|Find Your Ca | |
| Connected Investors | Connect With Real Estate Investors | |
| Connected Investors | Connect With Real Estate Investors | |
| Radiation Oncology Radiation Oncology Stanford Medicine | |
| Investors | Marathon Oil Corporation - Investors | |
| Allianz Global Investors | Individual Investors | |
| Allianz Global Investors | Individual Investors | |
| Allianz Global Investors Individual Investors | |
| Allianz Global Investors | Individual Investors | |
| OMNOVA Solutions - Investors - Investors |
ir.ziopharm.com Traffic Sources Chart
ir.ziopharm.com Alexa Rank History Chart
ir.ziopharm.com Html To Plain Text
Skip to main navigation Controlled IL-12 T-Cell Therapy Overview CAR-T Therapies TCRs for Solid Tumors Pipeline Patients & Caregivers About Overview Management Team Board of Directors Partnerships News & Publications Press Releases Scientific and Medical Publications Videos Investors Investor Relations Investors Home Press Releases Stock Performance SEC Filings Events & Presentations Corporate Governance Investor FAQs Email Alerts list Menu Close Close Controlled IL-12 T-Cell Therapy Overview CAR-T Therapies TCRs for Solid Tumors Pipeline Patients & Caregivers About Overview Management Team Board of Directors Partnerships News & Publications Press Releases Scientific and Medical Publications Videos Investors Investors Home Press Releases Stock Performance Stock Information Historic Stock Lookup Investment Calculator Financial Reports SEC Filings Events & Presentations Corporate Governance Medical Advisory Board Board of Directors Committees & Charters Investor FAQ Email Alerts Investors & Media Multiple opportunities for immuno-oncology Investors Home Ziopharm Oncology is focused on advancing the next generation of immunotherapies to weaponize the existing immune system with Controlled IL-12 or introduce new immune system elements with Sleeping Beauty -modified T cells to this fight against cancer. In addition to developing the next generation of immuno-oncology medicines that target multiple types of cancers, we also are targeting the cost and complexity of delivering gene and cell therapies. Intra 3 mo. 6 mo. 1 yr. Press Releases Mar 02, 2020 Summary Toggle Ziopharm Oncology Reports Financial Results for Fourth Quarter and Full Year 2019 Feb 28, 2020 Summary Toggle Ziopharm Oncology Presentation at the Barclays Global Healthcare Conference to be Webcast Feb 24, 2020 Summary Toggle Ziopharm Oncology to Host Conference Call to Discuss Fourth Quarter and Full Year 2019 Results on March 2, 2020 View all press releases » Events & Presentations Mar 11, 2020 2:35 PM EDT Barclays Global Healthcare Conference Add to Outlook Add to Google Calendar Mar 2, 2020 4:30 PM EST Ziopharm Fourth Quarter 2019 Earnings Call Listen to Webcast Supporting Materials View Presentation 534.4 KB Jan 16, 2020 1:00 PM EST Ziopharm Oncology 38th Annual J.P. Morgan Healthcare Conference - Q&A Listen to Webcast View all events & presentations » Corporate Contact: Christopher Taylor, Vice President, Investor Relations and Corporate Communications (617) 502-1881 ctaylor@ziopharm.com Email Alerts Subscription RSS News Feeds Print Share > Facebook Google LinkedIn Twitter RSS © 2020 Ziopharm Oncology, Inc. Privacy Policy Terms and Conditions Contact Vimeo Twitter --...
ir.ziopharm.com Whois
"domain_name": "ZIOPHARM.COM",
"registrar": "GoDaddy.com, LLC",
"whois_server": "whois.godaddy.com",
"referral_url": null,
"updated_date": [
"2019-12-12 19:09:43",
"2019-12-12 19:09:40"
],
"creation_date": "2004-01-12 21:25:25",
"expiration_date": "2022-01-12 21:25:25",
"name_servers": [
"NS47.DOMAINCONTROL.COM",
"NS48.DOMAINCONTROL.COM"
],
"status": [
"clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited",
"clientRenewProhibited https://icann.org/epp#clientRenewProhibited",
"clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited",
"clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited",
"clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited",
"clientRenewProhibited http://www.icann.org/epp#clientRenewProhibited",
"clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited"
],
"emails": [
"abuse@godaddy.com",
"ZIOPHARM.COM@domainsbyproxy.com"
],
"dnssec": "unsigned",
"name": "Registration Private",
"org": "Domains By Proxy, LLC",
"address": [
"DomainsByProxy.com",
"14455 N. Hayden Road"
],
"city": "Scottsdale",
"state": "Arizona",
"zipcode": "85260",
"country": "US"